Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Cash (2020 - 2025)

Maravai Lifesciences Holdings has reported Change in Cash over the past 6 years, most recently at -$26.7 million for Q4 2025.

  • Quarterly results put Change in Cash at -$26.7 million for Q4 2025, up 89.57% from a year ago — trailing twelve months through Dec 2025 was -$105.5 million (up 58.22% YoY), and the annual figure for FY2025 was -$105.5 million, up 58.22%.
  • Change in Cash for Q4 2025 was -$26.7 million at Maravai Lifesciences Holdings, down from -$26.3 million in the prior quarter.
  • Over the last five years, Change in Cash for MRVI hit a ceiling of $172.9 million in Q3 2021 and a floor of -$255.8 million in Q4 2024.
  • Median Change in Cash over the past 5 years was -$2.2 million (2023), compared with a mean of -$964700.0.
  • Biggest five-year swings in Change in Cash: skyrocketed 1550.69% in 2021 and later crashed 5408.46% in 2024.
  • Maravai Lifesciences Holdings' Change in Cash stood at $3.4 million in 2021, then skyrocketed by 335.45% to $14.7 million in 2022, then crashed by 131.6% to -$4.6 million in 2023, then crashed by 5408.46% to -$255.8 million in 2024, then soared by 89.57% to -$26.7 million in 2025.
  • The last three reported values for Change in Cash were -$26.7 million (Q4 2025), -$26.3 million (Q3 2025), and -$15.1 million (Q2 2025) per Business Quant data.